Código QR

Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes

Abstract Aims Left ventricular hypertrophy (LVH) has been associated with an increased risk of cardiovascular (CV) disease and linked to increased morbidity and mortality. In patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), hypertension is common, and patients with these co‐morb...

ver descrição completa

Na minha lista:
Principais autores: Gerasimos Filippatos, Stefan D. Anker, George L. Bakris, Peter Rossing, Luis M. Ruilope, Andrew J.S. Coats, Stephan vonHaehling, Piotr Ponikowski, Giuseppe M.C. Rosano, Meike Brinker, Alfredo E. Farjat, Luke Roberts, Bertram Pitt, the FIDELIO‐DKD and FIGARO‐DKD investigators
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2025-02-01
Colecção:ESC Heart Failure
Assuntos:
Cardiorenal outcomes
Chronic kidney disease
Finerenone
Hospitalization for heart failure
Left ventricular hypertrophy
Type 2 diabetes
Acesso em linha:https://doi.org/10.1002/ehf2.14962
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados